Search

everythinglearnresearchcommunity

for

Search:↓

Children with atopic dermatitis often have sleep problems, affecting their growth and behavior.

Stress increases nerve fibers and immune cell activity in mouse skin, possibly worsening skin conditions.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Testosterone treatment in trans men increases body and facial hair and may lead to hair loss over time, but severe skin issues are rare.

Manipulating the catagen and telogen phases of hair growth could lead to treatments for hair disorders.

Stress increases a factor in mice that leads to hair loss, and blocking this factor may prevent it.

Treating psoriasis on the scalp, nails, and skin folds is challenging, often requiring systemic treatments for severe cases, with some success in topical and biologic treatments.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

The document concludes that proper diagnosis and a multidisciplinary approach are crucial for managing Congenital Adrenal Hyperplasia effectively.

The document concludes that certain genetic mutations and dietary factors are involved in acne development, and treatments like isotretinoin and diet changes can help manage it.

Finasteride may cause slight depression and anxiety.

Hair follicles are hormone-sensitive and involved in growth and other functions, with potential for new treatments, but more research is needed.

Dutasteride 0.5 mg works better than finasteride and placebo for increasing hair in men with hair loss.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

A wearable device using electric stimulation can significantly improve hair growth.

Men over 66 taking medication for prostate enlargement have a higher risk of depression and self-harm, especially in the first 18 months of treatment.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

The document concludes that early diagnosis and treatment of Congenital Adrenal Hyperplasia are crucial for preventing serious health issues and improving patient outcomes.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

To diagnose hair loss, use a systematic approach including history, exams, and tests.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

FPHL is a common, age-related, genetic hair loss with unclear causes and limited treatment options.

Women with PCOS are more likely to suffer from depression, anxiety, and stress.

The document concludes that hirsutism is the main sign for diagnosing hyperandrogenism, which requires a detailed patient history and physical exam.

The document concludes that rapid identification, isolation, and strict infection control are crucial to manage SARS outbreaks.

Clomipramine may significantly reduce hair-pulling in Trichotillomania, but more research is needed on treatments and early onset cases.

Choosing the right recall period for patient feedback is important for accurate data and depends on the disease, symptom changes, and patient impact.

Certain steroids in the brain affect mood and symptoms of depression, and treatments targeting these steroids show promise for improving these symptoms.

The document concludes that minoxidil and finasteride are proven for hair growth, herbal remedies show promise, but more research is needed to confirm their effectiveness.

Hair shedding is an active process that could be targeted to treat hair loss.